JP2009542613A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009542613A5 JP2009542613A5 JP2009517423A JP2009517423A JP2009542613A5 JP 2009542613 A5 JP2009542613 A5 JP 2009542613A5 JP 2009517423 A JP2009517423 A JP 2009517423A JP 2009517423 A JP2009517423 A JP 2009517423A JP 2009542613 A5 JP2009542613 A5 JP 2009542613A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- pharmaceutically acceptable
- acceptable salt
- general formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 14
- 150000003839 salts Chemical class 0.000 claims 7
- 238000000034 method Methods 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 3
- 239000002671 adjuvant Substances 0.000 claims 2
- 150000001412 amines Chemical class 0.000 claims 2
- 239000003085 diluting agent Substances 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- KWSTUZCCOARWHV-BRTIRZTQSA-N 4-[(9-cyclopentyl-5-methyl-6-oxospiro[8h-pyrimido[4,5-b][1,4]diazepine-7,1'-cyclopropane]-2-yl)amino]-3-fluoro-n-[(1r,5s)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]benzamide Chemical compound C([C@]1(CCC[C@@](C2)(N1C)[H])[H])C2NC(=O)C(C=C1F)=CC=C1NC(N=C1N(C2CCCC2)C2)=NC=C1N(C)C(=O)C12CC1 KWSTUZCCOARWHV-BRTIRZTQSA-N 0.000 claims 1
- 101000582926 Dictyostelium discoideum Probable serine/threonine-protein kinase PLK Proteins 0.000 claims 1
- 239000005977 Ethylene Substances 0.000 claims 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 1
- 125000004185 ester group Chemical group 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 239000011737 fluorine Substances 0.000 claims 1
- 150000002431 hydrogen Chemical class 0.000 claims 1
- 230000007062 hydrolysis Effects 0.000 claims 1
- 238000006460 hydrolysis reaction Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 0 C*C(*)(C(*)(*)N(*)c1nc(Nc2c(C)c(C)c(C(NCN*)=O)c(*)c2)ncc1N1C)C1=O Chemical compound C*C(*)(C(*)(*)N(*)c1nc(Nc2c(C)c(C)c(C(NCN*)=O)c(*)c2)ncc1N1C)C1=O 0.000 description 3
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81887806P | 2006-07-06 | 2006-07-06 | |
| PCT/GB2007/002490 WO2008003958A2 (en) | 2006-07-06 | 2007-07-05 | Fused pyrimido compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009542613A JP2009542613A (ja) | 2009-12-03 |
| JP2009542613A5 true JP2009542613A5 (https=) | 2010-08-05 |
Family
ID=38857945
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009517423A Pending JP2009542613A (ja) | 2006-07-06 | 2007-07-05 | 新規化合物 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7709471B2 (https=) |
| EP (1) | EP2046793A2 (https=) |
| JP (1) | JP2009542613A (https=) |
| KR (1) | KR20090038895A (https=) |
| CN (1) | CN101511836A (https=) |
| AR (1) | AR061850A1 (https=) |
| AU (1) | AU2007270931A1 (https=) |
| BR (1) | BRPI0714045A2 (https=) |
| CA (1) | CA2656936A1 (https=) |
| CL (1) | CL2007001973A1 (https=) |
| EC (1) | ECSP099044A (https=) |
| IL (1) | IL196207A0 (https=) |
| MX (1) | MX2009000220A (https=) |
| NO (1) | NO20090052L (https=) |
| RU (1) | RU2009103810A (https=) |
| TW (1) | TW200808325A (https=) |
| UY (1) | UY30472A1 (https=) |
| WO (1) | WO2008003958A2 (https=) |
| ZA (1) | ZA200900073B (https=) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8063050B2 (en) * | 2006-07-06 | 2011-11-22 | Array Biopharma Inc. | Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors |
| ATE532789T1 (de) | 2006-07-06 | 2011-11-15 | Array Biopharma Inc | Dihydrothienopyrimidine als akt-proteinkinase- inhibitoren |
| EP2049500B1 (en) | 2006-07-06 | 2011-09-07 | Array Biopharma, Inc. | Cyclopenta [d] pyrimidines as akt protein kinase inhibitors |
| US8329701B2 (en) | 2006-07-06 | 2012-12-11 | Array Biopharma Inc. | Dihydrofuro pyrimidines as AKT protein kinase inhibitors |
| WO2008113711A1 (en) | 2007-03-22 | 2008-09-25 | F. Hoffmann-La Roche Ag | Substituted pyrimidodiazepines useful as plk1 inhibitors |
| US9409886B2 (en) | 2007-07-05 | 2016-08-09 | Array Biopharma Inc. | Pyrimidyl cyclopentanes as AKT protein kinase inhibitors |
| CN101918373B (zh) | 2007-07-05 | 2013-06-05 | 阵列生物制药公司 | 作为akt蛋白激酶抑制剂的嘧啶基环戊烷 |
| US8846683B2 (en) | 2007-07-05 | 2014-09-30 | Array Biopharma, Inc. | Pyrimidyl cyclopentanes as Akt protein kinase inhibitors |
| CA2695753A1 (en) * | 2007-08-15 | 2009-02-19 | Vertex Pharmaceuticals Incorporated | Compounds useful as protein kinases inhibitors |
| WO2009042711A1 (en) * | 2007-09-25 | 2009-04-02 | Takeda Pharmaceutical Company Limited | Polo-like kinase inhibitors |
| EP2205603B1 (en) | 2007-09-28 | 2014-01-15 | Cyclacel Limited | Pyrimidine derivatives as protein kinase inhibitors |
| WO2009067547A1 (en) * | 2007-11-19 | 2009-05-28 | Takeda Pharmaceutical Company Limited | Polo-like kinase inhibitors |
| NZ586346A (en) | 2008-01-09 | 2012-02-24 | Array Biopharma Inc | Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| US8853216B2 (en) | 2008-01-09 | 2014-10-07 | Array Biopharma, Inc. | Hydroxylated pyrimidyl cyclopentane as AKT protein kinase inhibitor |
| JP2011527667A (ja) | 2008-06-18 | 2011-11-04 | 武田薬品工業株式会社 | ハロ置換ピリミドジアゼピン |
| EP4585589A3 (en) * | 2008-12-03 | 2025-11-19 | The Scripps Research Institute | Stem cell cultures |
| EP2379559B1 (en) | 2009-01-06 | 2017-10-25 | Dana-Farber Cancer Institute, Inc. | Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders |
| RS57869B1 (sr) | 2009-06-17 | 2018-12-31 | Vertex Pharma | Inhibitori replikacije virusa gripa |
| TWI399551B (zh) * | 2009-06-26 | 2013-06-21 | Senao Networks Inc | Burner device and burner method |
| SG179206A1 (en) | 2009-09-25 | 2012-04-27 | Vertex Pharma | Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors |
| CA2773827A1 (en) * | 2009-09-25 | 2011-03-31 | Vertex Pharmaceuticals Incorporated | Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors |
| US8466155B2 (en) * | 2009-10-02 | 2013-06-18 | Boehringer Ingelheim International Gmbh | Pyrimidines |
| US20110218295A1 (en) * | 2010-03-02 | 2011-09-08 | Basf Se | Anionic associative rheology modifiers |
| US8673275B2 (en) | 2010-03-02 | 2014-03-18 | Basf Se | Block copolymers and their use |
| AU2011343642A1 (en) | 2010-12-16 | 2013-05-02 | Vertex Pharmaceuticals Incorporated | Inhibitors of influenza viruses replication |
| TR201815685T4 (tr) | 2011-04-01 | 2018-11-21 | Genentech Inc | Kanser tedavisi için akt ve mek inhibe edici bileşiklerin kombinasyonları. |
| KR102021157B1 (ko) | 2011-04-01 | 2019-09-11 | 제넨테크, 인크. | Ａｋｔ 억제제 화합물 및 아비라테론의 조합물, 및 사용 방법 |
| UA118010C2 (uk) | 2011-08-01 | 2018-11-12 | Вертекс Фармасьютікалз Інкорпорейтед | Інгібітори реплікації вірусів грипу |
| GB201205752D0 (en) * | 2012-03-30 | 2012-05-16 | Cyclacel Ltd | Treatment |
| HRP20181272T1 (hr) | 2013-11-13 | 2018-10-05 | Vertex Pharmaceuticals Incorporated | Postupci priprave inhibitora replikacije virusa influence |
| RS59144B1 (sr) | 2013-11-13 | 2019-09-30 | Vertex Pharma | Inhibitori replikacije virusa influence |
| GB201403536D0 (en) | 2014-02-28 | 2014-04-16 | Cancer Rec Tech Ltd | Inhibitor compounds |
| JP6857617B2 (ja) | 2015-05-13 | 2021-04-14 | バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ | インフルエンザウイルスの複製の阻害剤 |
| JP6704416B2 (ja) | 2015-05-13 | 2020-06-03 | バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ | インフルエンザウイルスの複製の阻害剤を調製する方法 |
| CN107949279A (zh) * | 2015-07-06 | 2018-04-20 | 得克萨斯系统大学评议会 | 可用作用于治疗人类癌症的抗癌剂的苯甲酰胺或苯扎明化合物 |
| US11155556B2 (en) * | 2016-04-07 | 2021-10-26 | Dana-Farber Cancer Institute, Inc. | Pyrimido-diazepinone kinase scaffold compounds and methods for treating PI3K-mediated disorders |
| CN115485025A (zh) * | 2020-02-28 | 2022-12-16 | 雷密克斯医疗公司 | 用于调节剪接的化合物和方法 |
| WO2022145989A1 (ko) * | 2020-12-31 | 2022-07-07 | (주) 업테라 | 선택적 plk1 억제제로서의 피리미도디아제핀 유도체 |
| EP4157849A4 (en) * | 2021-08-10 | 2024-12-11 | Uppthera, Inc. | NOVEL PLK1 DEGRADATION-INDUCING COMPOUND |
| WO2023034812A1 (en) * | 2021-08-30 | 2023-03-09 | Remix Therapeutics Inc. | Compounds and methods for modulating splicing |
| CN114392258B (zh) * | 2021-12-30 | 2024-04-16 | 北京朗瑞邦科技有限公司 | 一种4H-吡喃并[2,3-c]吡啶-4-酮类化合物药物制剂及其制备方法 |
| CN113999244B (zh) * | 2021-12-30 | 2022-05-20 | 北京鑫开元医药科技有限公司 | 一种4H-吡喃并[2,3-c]吡啶-4-酮类化合物及其制备方法 |
| TW202345806A (zh) | 2022-03-31 | 2023-12-01 | 美商艾伯維有限公司 | 噻唑并〔５，４－ｂ〕吡啶ｍａｌｔ－１抑制劑 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1427730E (pt) | 2001-09-04 | 2006-11-30 | Boehringer Ingelheim Pharma | Novas di-hidropteridinonas, processo para sua preparação e sua utilização como medicamento |
| US6806272B2 (en) | 2001-09-04 | 2004-10-19 | Boehringer Ingelheim Pharma Kg | Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions |
| BR0318145A (pt) | 2003-02-26 | 2006-02-21 | Boehringer Ingelheim Pharma | dihidropteridinonas, processos para a sua preparação e sua aplicação como medicamento |
| US6861422B2 (en) | 2003-02-26 | 2005-03-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions |
| DE102004029784A1 (de) | 2004-06-21 | 2006-01-05 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue 2-Benzylaminodihydropteridinone, Verfahren zur deren Herstellung und deren Verwendung als Arzneimittel |
| DE102004034623A1 (de) | 2004-07-16 | 2006-02-02 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue 6-Formyl-tetrahydropteridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| US20060074088A1 (en) | 2004-08-14 | 2006-04-06 | Boehringer Ingelheim International Gmbh | Dihydropteridinones for the treatment of cancer diseases |
| US7759485B2 (en) | 2004-08-14 | 2010-07-20 | Boehringer Ingelheim International Gmbh | Process for the manufacture of dihydropteridinones |
| US7728134B2 (en) * | 2004-08-14 | 2010-06-01 | Boehringer Ingelheim International Gmbh | Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament |
| US20060058311A1 (en) | 2004-08-14 | 2006-03-16 | Boehringer Ingelheim International Gmbh | Combinations for the treatment of diseases involving cell proliferation |
| US20060035903A1 (en) | 2004-08-14 | 2006-02-16 | Boehringer Ingelheim International Gmbh | Storage stable perfusion solution for dihydropteridinones |
| EP1632493A1 (de) | 2004-08-25 | 2006-03-08 | Boehringer Ingelheim Pharma GmbH & Co.KG | Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
| EP1630163A1 (de) | 2004-08-25 | 2006-03-01 | Boehringer Ingelheim Pharma GmbH & Co.KG | Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
| CA2575804A1 (en) | 2004-08-26 | 2006-03-02 | Boehringer Ingelheim International Gmbh | Pteridinones used as plk (polo like kinase) inhibitors |
| JP2008510771A (ja) | 2004-08-27 | 2008-04-10 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ジヒドロプテリジノン、その製造方法および医薬薬剤としてのその使用 |
| US7439358B2 (en) | 2006-02-08 | 2008-10-21 | Boehringer Ingelheim International Gmbh | Specific salt, anhydrous and crystalline form of a dihydropteridione derivative |
| TW200804389A (en) | 2006-02-14 | 2008-01-16 | Vertex Pharma | Dihydrodiazepines useful as inhibitors of protein kinases |
-
2007
- 2007-06-28 TW TW096123500A patent/TW200808325A/zh unknown
- 2007-07-05 MX MX2009000220A patent/MX2009000220A/es not_active Application Discontinuation
- 2007-07-05 CA CA002656936A patent/CA2656936A1/en not_active Abandoned
- 2007-07-05 US US11/773,674 patent/US7709471B2/en not_active Expired - Fee Related
- 2007-07-05 KR KR1020097002535A patent/KR20090038895A/ko not_active Withdrawn
- 2007-07-05 RU RU2009103810/04A patent/RU2009103810A/ru not_active Application Discontinuation
- 2007-07-05 EP EP07733455A patent/EP2046793A2/en not_active Withdrawn
- 2007-07-05 WO PCT/GB2007/002490 patent/WO2008003958A2/en not_active Ceased
- 2007-07-05 CN CNA2007800331017A patent/CN101511836A/zh active Pending
- 2007-07-05 BR BRPI0714045-2A patent/BRPI0714045A2/pt not_active IP Right Cessation
- 2007-07-05 CL CL200701973A patent/CL2007001973A1/es unknown
- 2007-07-05 AU AU2007270931A patent/AU2007270931A1/en not_active Abandoned
- 2007-07-05 JP JP2009517423A patent/JP2009542613A/ja active Pending
- 2007-07-06 UY UY30472A patent/UY30472A1/es unknown
- 2007-07-06 AR ARP070103042A patent/AR061850A1/es not_active Application Discontinuation
-
2008
- 2008-12-25 IL IL196207A patent/IL196207A0/en unknown
-
2009
- 2009-01-05 ZA ZA200900073A patent/ZA200900073B/xx unknown
- 2009-01-06 NO NO20090052A patent/NO20090052L/no not_active Application Discontinuation
- 2009-01-09 EC EC2009009044A patent/ECSP099044A/es unknown